Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...

Pfizer's stock declined over 50% due to reduced sales ... The remarkable improvement was driven by the strong performance of Pfizer's core portfolio, particularly its drugs that treat cancer ...

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust ...

On May 21, analyst Geoff Meacham of Citi maintained a Hold rating on Pfizer Inc. (NYSE:PFE), reiterating the price target of ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

The stock's fall snapped a four-day winning streak.

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Gujarat Gas Limited, Quess Corp, Power Finance Corporation, and Eris Lifesciences Limited will also report their quarterly ...